Association between age-related decline of kidney function and plasma malondialdehyde

Rejuvenation Research

Volumn 15, Issue 3, 2012, Pages 257-264

  Li, Guolin ^a   Chen, Yaqin ^a   Hu, Hui ^a   Liu, Li ^a   Hu, Xiaofei ^a   Wang, Jun ^a   Shi, Wang ^a   Yin, Dazhong ^a  

^a HUNAN NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MALONALDEHYDE;

ADULT; AGING; ARTICLE; BLOOD LEVEL; CHINESE; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MILD INSUFFICIENCY OF KIDNEY FUNCTION; OXIDATIVE STRESS; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGING; ALCOHOL DRINKING; BODY MASS INDEX; CONFIDENCE INTERVALS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; MALE; MALONDIALDEHYDE; MIDDLE AGED; MOTOR ACTIVITY; ODDS RATIO; RENAL INSUFFICIENCY, CHRONIC; SLEEP; SMOKING;

EID: 84863460571     PISSN: 15491684     EISSN: 15578577     Source Type: Journal    
DOI: 10.1089/rej.2011.1259     Document Type: Article

References (44)

1. Yin DZ, Chen KJ. The essential mechanisms of aging: Irreparable damage accumulation of biochemical side-reactions. Exp Gerontol 2005;40:455-465.
2. Gourtsoyiannis N, Prassopoulos P, Cavouras D, Pantelidis N. The thickness of the renal parenchyma decreases with age: A CT study of 360 patients. AJR. Am J Roentgenol 1990; 155:541-544. (Pubitemid 20254498)
3. Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW. The effect of age on creatinine clearance in men: A cross-sectional and longitudinal study. J Gerontol 1976;31:155-163.
4. Fehrman-Ekholm I, Skeppholm L. Renal function in the elderly ( > 70 years old) measured by means of iohexol clearance, serum creatinine, serum urea and estimated clearance. Scand J Urol Nephro 2004;38:73-77. (Pubitemid 38241426)
5. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levery AS. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-2047. (Pubitemid 350074801)
6. Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; for the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612.
7. van der Zee S, Baber U, Elmariah S, Winston J, Fuster V. Cardiovascular risk factors in patients with chronic kidney disease. Nat Rev Cardiol 2009;6:580-589.
8. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: Effects on the cardiovascular system. Circulation 2007;116: 85-97. (Pubitemid 47016250)
9. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C-y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351: 1296-1305.
10. Salmon AH, Neal CR, Harper SJ. New aspects of glomerular filtration barrier structure and function: Five layers (at least) not three. Curr Opin Nephrol Hypertens 2009;18: 197-205.
11. Kim J, Sohn E, Kim CS, Kim JS. Renal podocyte apoptosis in Zucker diabetic fatty rats: Involvement of methylglyoxalinduced oxidative DNA damage. J Comp Pathol 2011;14 4:41-47.
12. Tojo A, Asaba K, Onozato ML. Suppressing renal NADPH oxidase to treat diabetic nephropathy. Expert Opin Ther Targets 2007;11:1011-1018. (Pubitemid 47232619)
13. Nagasu H, Satoh M, Yorimitsu D, Tomita N, Sasaki T, Kashihara N. Comparison of combination therapy of olmesartan plus azelnidipine or hydrochlorothiazide on renal and vascular damage in SHR/NDmcr-cp rats. Kidney Blood Press Res 2011;34:87-96.
14. Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008;57:1446-1454.
15. Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, Alp Ikizler T, Himmelfarb J. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 2004;65:1009-1016. (Pubitemid 38251077)
16. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 2000;408:239-247.
17. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes 1999;48:1-9. (Pubitemid 29019345)
18. Silva E, Pinto V, Simao S, Serrao MP, Afonso J, Amaral J, Pinho MJ, Gomes P, Soares-da-Silva P. Renal aging in WKY rats: changes in Na +,K +-ATPase function and oxidative stress. Exp Gerontol 2010;45:977-983.
19. Uribarri J, Cai W, Peppa M, Goodman S, Ferrucci L, Striker G, Vlassara H. et al. Circulating glycotoxins and dietary advanced glycation endproducts: Two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci 2007;62:427-433. (Pubitemid 47065712)
20. Swaminathan S, Shah SV. Novel approaches targeted toward oxidative stress for the treatment of chronic kidney disease. Curr Opin Nephrol Hypertens 2008;17:143-148. (Pubitemid 351253038)
21. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: An emerging threat to patient outcome. Nephrol Dial Transplant 2003;18:1272-1280. (Pubitemid 36826946)
22. Lee JH, Jung KJ, Kim JW, Kim HJ, Yu BP, Chung HY. Suppression of apoptosis by calorie restriction in aged kidney. Exp Gerontol 2004;39:1361-1368. (Pubitemid 39360377)
23. Qiao X, Chen X, Wu D, Ding R, Wang J, Hong Q, Shi S, Li J, Xie Y, Lu Y, Wang Z. Mitochondrial pathway is responsible for aging-related increase of tubular cell apoptosis in renal ischemia/reperfusion injury. J Gerontol A Biol Sci Med Sci 2005;60:830-839. (Pubitemid 41098626)
24. Choksi KB, Nuss JE, Boylston WH, Rabek JP, Papaconstantinou J. Age-related increases in oxidatively damaged proteins of mouse kidney mitochondrial electron transport chain complexes. Free Radic Biol Med 2007;43:1423-1438. (Pubitemid 47532365)
25. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G; National Kideny Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 2003;139:137-147.
26. National-Kidney-Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 1):S1-S266.
27. Baskurt OK, Boynard M, Cokelet GC, Connes P, Cooke BM, Forconi S, Liao F, Hardeman MR, Jung F, Meiselman HJ, Nash G, Nemeth N, Neu B, Sandhagen B, Shin S, Thurston G, Wautier JL; International Expert Panel for Standardization of Hemorheological Methods. New guidelines for hemorheological laboratory techniques. Clin Hemorheol Microcirc 2009;42:75-97.
28. Chen K, Xie F, Liu S, Li G, Chen Y, Shi W, Hu H, Liu L, Yin D. Plasma reactive carbonyl species: Potential risk factor for hypertension. Free Radic Res 2011;45:568-574.
29. WHO-Expert-Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-163.
30. Liu S, Shi W, Li G, Jin B, Chen Y, Hu H, Liu L, Xie F, Chen K, Yin D. Plasma reactive carbonyl species levels and risk of nonalcoholic fatty liver disease. J Gastroenterol Hepatol 2011;26:1010-1015.
31. Li G, He H, Yan H, Zhao Q, Yin D. Does carbonyl stress cause increased blood viscosity during storage? Clin Hemorheol Microcirc 2010;44:145-154.
32. Hosmer DW, Lemeshow S. Applied Logistic Regression, 2nd ed. Wiley, New York, 2000.
33. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003;41:1-12. (Pubitemid 36043346)
34. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985;33:278-285. (Pubitemid 15087125)
35. Dols LF, Weimar W, Ijzermans JN. Long-term consequences of kidney donation. N Engl J Med 2009;360:2371-2372; author reply 2372.
36. Pizzarelli F, Lauretani F, Bandinelli S, Windham GB, Corsi AM, Giannelli SV, Ferrucci L, Guralnik JM. Predictivity of survival according to different equations for estimating renal function in community-dwelling elderly subjects. Nephrol Dial Transplant 2009;24:1197-1205.
37. Kadiiska MB, Gladen BC, Baird DD, Germolec D, Graham LB, Parker CE, Nyska A, Wachsman JT, Ames BN, Basu S, Brot N, Fitzgerald GA, Floyd RA, George M, Heinecke JW, Hatch GE, Hensley K, Lawson JA, Marnett LJ, Morrow JD, Murray DM, Plastaras J, Roberts LJ 2nd, Rokach J, Shigenaga MK, Sohal RS, Sun J, Tice RR, Van Thiel DH, Wellner D, Walter PB, Tomer KB, Mason RP, Barrett JC. Biomarkers of oxidative stress study II. Are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med 2005;38:698-710. (Pubitemid 40249740)
38. Gil L, Siems W, Mazurek B, Gross J, Schroeder P, Voss P, Grune T. Age-associated analysis of oxidative stress parameters in human plasma and erythrocytes. Free Radic Res 2006;40:495-505.
39. Aldini G, Dalle-Donne I, Colombo R, Maffei Facino R, Molzani A, Carini M. Lipoxidation-derived reactive carbonyl species as potential drug targets in preventing protein carbonylation and related cellular dysfunction. ChemMed-Chem 2006;1:1045-1058. (Pubitemid 44622243)
40. Levine RL, Stadtman ER. Carbonylated proteins and their implication in physiology and pathology. In: Desiderio DM, Nibbering NM (eds). Redox Proteomics: From Protein Modifications to Cellular Dysfunction and Diseases, vol 1. John Wiley & Sons, Inc., New Jersey, 2006, pp. 123-168.
41. Weismann D, Hartvigsen K, Lauer N, Bennett KL, Scholl HP, Charbel Issa P, CanoM, Brandstatter H, Tsimikas S, Skerka C, Superti-Furga G, Handa JT, Zipfel PF, Witztum JL, Binder CJ. Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 2011;478:76-81.
42. Kang Z, Li H, Li G, Yin D. Reaction of pyridoxamine with malondialdehyde: Mechanism of inhibition of formation of advanced lipoxidation end-products. Amino Acids 2006;30: 55-61. (Pubitemid 43261127)
43. Li G, Li L, Yin D. A novel observation:Melatonin's interaction with malondiadehyde. Neuroendocrinol Lett 2005;26:61-66.
44. Roberts LJ, Morrow JD. Measurement of F-2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000;28:505-513. (Pubitemid 30136031)